Bo Wang

Beijing Chnmed Consulting Co. Ltd. operates the Qinmai Pharmaceutical Network and is a technology-driven pharmaceutical consulting firm specializing in comprehensive services that support the pharmaceutical industry’s development. The company is based in BE. The Chinese company offers strategic planning, market research, policy analysis, GMP certification consulting, regulatory affairs, clinical research support, and investment advisory services. Chnmed provides tailored solutions and long-term partnerships to help clients navigate evolving policies, optimize resources, and enhance competitiveness. Its expertise includes drug registration, clinical trial design and monitoring, medical statistics, government affairs consulting, and intellectual property, supported by strong industry relationships with regulatory agencies and experts. The firm publishes pharmaceutical market intelligence reports and reference materials such as GMP guidelines and clinical drug databases. Chnmed also develops innovative traditional Chinese medicines, including class 1 drugs targeting coronary heart disease and angina pectoris, combining modern purification technologies with traditional herbal components.

China National Association of Pharmaceuticals & Medical Equi is a private company based in BE.

Manufactures and markets digestion, cardiovascular, tumor and anti-infective pharmaceutical drugs

Distributes and retails pharmaceuticals and medical devices

Manufactures pharmaceutical products

Functions as a College/University